
Corteva CTVA
$ 67.26
-0.06%
Quarterly report 2025-Q3
added 11-05-2025
Corteva General and Administrative Expenses 2011-2025 | CTVA
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Corteva
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.2 B | 3.18 B | 3.17 B | 3.21 B | 3.04 B | 3.06 B | 2.9 B | 2.97 B | 2.94 B | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.21 B | 2.9 B | 3.07 B |
Quarterly General and Administrative Expenses Corteva
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 725 M | 1.16 B | 751 M | - | 671 M | 1.05 B | 736 M | - | 670 M | 1.04 B | 726 M | - | 657 M | 1.02 B | 735 M | - | 672 M | 998 M | 733 M | - | 597 M | 965 M | 757 M | - | 646 M | 937 M | 735 M | - | 633 M | 965 M | 959 M | 920 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.16 B | 597 M | 818 M |
General and Administrative Expenses of other stocks in the Agricultural inputs industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Акрон
AKRN
|
32.1 B | - | - | - | ||
|
China Green Agriculture
CGA
|
24.4 M | - | 0.51 % | $ 27.6 M | ||
|
ФосАгро
PHOR
|
6.93 B | - | - | - | ||
|
CF Industries Holdings
CF
|
320 M | $ 77.4 | -0.19 % | $ 14 B | ||
|
ICL Group Ltd
ICL
|
276 M | $ 5.55 | 3.64 % | $ 7.83 B | ||
|
FMC Corporation
FMC
|
645 M | $ 13.48 | 1.01 % | $ 1.68 B | ||
|
Marrone Bio Innovations
MBII
|
30.6 M | - | -5.9 % | $ 180 M | ||
|
Nutrien Ltd.
NTR
|
477 M | $ 62.72 | -1.32 % | $ 34.8 B | ||
|
American Vanguard Corporation
AVD
|
120 M | $ 3.97 | -0.5 % | $ 111 M | ||
|
Intrepid Potash
IPI
|
33 M | $ 28.2 | -0.46 % | $ 363 M | ||
|
The Mosaic Company
MOS
|
497 M | $ 24.26 | 0.1 % | $ 7.76 B | ||
|
Origin Agritech Limited
SEED
|
73.3 M | $ 1.15 | -5.74 % | $ 6.46 M | ||
|
CVR Partners, LP
UAN
|
28.4 M | $ 97.1 | 0.79 % | $ 1.03 B | ||
|
Arcadia Biosciences
RKDA
|
14.5 M | $ 2.56 | -15.79 % | $ 3.17 M | ||
|
Bioceres Crop Solutions Corp.
BIOX
|
47.6 M | $ 1.34 | -1.84 % | $ 435 M | ||
|
The Scotts Miracle-Gro Company
SMG
|
603 M | $ 57.83 | 0.03 % | $ 3.33 B | ||
|
Yield10 Bioscience
YTEN
|
6.15 M | - | 15.32 % | $ 46.6 M |